Recent Research

• 

  FIRST LOOK NOTES

  14 Aug 2026

  Burjeel Holdings PLC

  BUY

  Last Closing Price

  1.30

  Target Price

  1.70

  Upside (%)

  +30.77%

  UAE Equity Research - Burjeel Holding PLC 2Q26 - First Look Note

  Patient volumes increased 9.9% YOY to over 3.7 Mn in 1H26, with growth accelerating to 12.4% YOY in 2Q26. EBITDA declined 4.8% YOY to AED 291 Mn in 2Q26 due to non-recurring costs and the absence of the one-off gain recognized in 2Q25.

  Download
• 

  EARNINGS CALL INSIGHT

  13 Aug 2026

  Burjeel Holdings PLC

  BUY

  Last Closing Price

  1.28

  Target Price

  1.70

  Upside (%)

  +32.81%

  UAE Equity Research - Burjeel Holding PLC 2Q26 - Earnings Call Insight

  Burjeel Holdings revenue increased 3.7% YOY to AED 1,455 Mn in 2Q26, supported by a recovery in elective and high-acuity procedures, higher outpatient visits, and stronger inpatient activity. Excluding the impact of the Unified Procurement Program (UPP), normalized revenue grew 8.6% YOY in 2Q26.

  Download
• 

  INITIAL COVERAGE (EQUITIES)

  05 Jun 2026

  Burjeel Holdings PLC

  BUY

  Last Closing Price

  1.06

  Target Price

  1.70

  Upside (%)

  +60.38%

  UAE Equity Research - Burjeel Holdings PLC - Initiation Coverage

  We initiate coverage on Burjeel Holdings PLC (“Burjeel” or “the Company”) with an equity valuation of AED 1.70 per share. The Company is an integrated private healthcare provider in the GCC, operating a diversified network of hospitals, medical centers, pharmacies, and specialized healthcare facilities across the UAE, Oman, and Saudi Arabia. Established in 2007 and headquartered

  Download